Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. ICU Medical's Pre-Tax Income for the
three
months ended in Mar. 2024 was $-37 Mil. ICU Medical's Revenue for the
three
months ended in Mar. 2024 was $567 Mil. Therefore, ICU Medical's pretax margin for the quarter that ended in Mar. 2024 was -6.49%.
The historical rank and industry rank for ICU Medical's Pretax Margin % or its related term are showing as below:
ICUI'
s Pretax Margin % Range Over the Past 10 Years
Min: -5.02 Med: 8.37 Max: 22.45
Current: -4.51
ICUI's Pretax Margin % is ranked worse than 53.17% of 820
companies
in the Medical Devices & Instruments industry
Industry Median: -1.025
vs ICUI: -4.51
ICU Medical Pretax Margin % Historical Data
The historical data trend for ICU Medical's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ICU Medical's Pretax Margin %
For the Medical Instruments & Supplies subindustry, ICU Medical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical's Pretax Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where ICU Medical's Pretax Margin % falls into.
ICU Medical Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
ICU Medical's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (NAS:ICUI) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
ICU Medical Pretax Margin % Related Terms
Thank you for viewing the detailed overview of ICU Medical's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICUI has been successfully added to your 